Therapy News and Research

RSS

Pediatric asthma hospitalizations alert to poor disease management

Researchers from Italy say that the majority of hospitalizations for pediatric asthma reflect inadequate disease management rather than disease severity.

24 Oct 2013

Multifactorial approach needed for early bipolar detection

At-risk states for bipolar disorder require a multifaceted approach to be identified and appropriately treated, according to preliminary results from the Dresden High-Risk Project.

24 Oct 2013

Full and early treatment may cure babies with HIV

A report published in The New England Journal of Medicine provides confirmation of what researchers say is the first case of HIV remission in a child born with the virus.

24 Oct 2013

CVS Caremark receives PBM and DTM accreditation from URAC

CVS Caremark announced today that it has been awarded Pharmacy Benefit Management (PBM) and Drug Therapy Management accreditation from URAC, a Washington, DC-based health care accrediting organization that establishes quality standards for the health care industry.

24 Oct 2013

HM Hospitales expects to treat first patients with Elekta's Versa HD system in 2015

HM Hospitales, a private hospital group in Spain, anticipates treating its first patients with Elekta's Versa HD™ system in 2015. Versa HD, to be sited in the group's sixth hospital, is an advanced radiation treatment system designed to enhance the management of cancer care and treat a broad spectrum of tumors throughout the body.

From Elekta 24 Oct 2013

Study reveals that parental panic disorder affects children

Children of parents with anxiety disorders are more likely to develop anxiety disorders than children of normal controls . This familial aggregation is due to genetic and environmental influences, whereas it can be assumed that shared environmental influences have the greatest effects during childhood, decreasing with age.

24 Oct 2013

Alexion Pharma's replacement therapy gets FDA Breakthrough Therapy designation for MoCD Type A

Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has granted a Breakthrough Therapy designation to cyclic pyranopterin monophosphate (cPMP, or ALXN1101), an enzyme co-factor replacement therapy for the treatment of patients with molybdenum cofactor deficiency type A, a severe and life-threatening, ultra-rare, genetic metabolic disorder that causes catastrophic and irreversible neurologic damage within the first weeks of life.

24 Oct 2013

LCSB researchers publish current knowledge about the genetic, molecular causes of PD

Parkinson's disease continues to puzzle physicians and biologists alike - even though it is well-established that symptoms like muscle tremors, rigidity, and, during the final stages, immobility can all be traced back to the death of a certain type of brain cell called a dopaminergic neuron. The underlying cause of this cellular death is a complex web of interrelated genetic molecular processes as well as external factors, most of the details of which are well-known. But how the various factors correlate and influence each other continues to elude the scientific community.

24 Oct 2013

Study reveals that tumors factors inhibit repair of damaged muscle fibers during cancer wasting

A new study reveals that tumors release factors into the bloodstream that inhibit the repair of damaged muscle fibers, and that this contributes to muscle loss during cancer wasting.

24 Oct 2013

New Centre for Stratified Medicine opened in Ireland

The University of Ulster has opened a new Centre for Stratified Medicine. The only Centre of its kind in Ireland, £11.5m research facility in Derry~Londonderry puts the University at the forefront of medical research into chronic degenerative diseases.

24 Oct 2013

Thomas Jefferson University’s interactive program discusses pros and cons of prostate cancer treatment

When the pros and cons of prostate cancer treatment are spelled out using an online interactive program developed by Thomas Jefferson University researchers, more patients choose active surveillance over therapy, according to research being presented Wednesday (October 23rd) at the Society for Medical Decision Making annual meeting in Baltimore, Maryland.

24 Oct 2013

Leukemia drug reverses symptoms of colitis in lab tests

A drug currently on the market to treat leukemia reversed symptoms of colitis in lab tests, according to recently published findings by medical researchers with the University of Alberta.

24 Oct 2013

Researchers use nanopores to smuggle DNA or proteins across membranes

A living cell is built with barriers to keep things out - and researchers are constantly trying to find ways to smuggle molecules in.‬ ‪Professor Giovanni Maglia (Biochemistry, Molecular and Structural Biology, KU Leuven) and his team have engineered a biological nanopore that acts as a selective revolving door through a cell's lipid membrane. The nanopore could potentially be used in gene therapy and targeted drug delivery.‬‬‬‬‬‬‬

24 Oct 2013

Patient assistance programs help breast cancer patients to learn more about adjuvant therapy

Patient assistance programs can help breast cancer patients meet a variety of needs that can interfere with getting recommended adjuvant therapies such as radiation, chemotherapy, and hormonal treatments, according to a study published recently in the online edition of the Journal of Oncology Practice.

24 Oct 2013

Kaiser Permanente researchers named co-recipients of Drug Therapy Research Literature Award

Three Kaiser Permanente Colorado researchers have been named co-recipients of the prestigious Drug Therapy Research Literature Award, an award presented annually by the American Society of Health-System Pharmacists Foundation.

24 Oct 2013

Diffregen awarded SBIR Phase 1 grant to advance Angiocidin towards human clinical trials

Diffregen LLC, a Temple University startup company, has been awarded a small business innovation research Phase 1 grant by the National Cancer Institute to advance Angiocidin, a university-created therapeutic to treat acute myeloid leukemia, to the doorstep of human clinical trials.

24 Oct 2013

Metformin could serve as radiosensitizer to treat patients with stage III non-small cell lung cancer

Treating aggressive lung cancer with the diabetes drug metformin along with radiation and chemotherapy may slow tumor growth and recurrence, suggests new preliminary findings from researchers at the Perelman School of Medicine at the University of Pennsylvania being presented during an oral abstract session October 28 at the 15th World Conference on Lung Cancer.

24 Oct 2013

Researchers improve cytostatic therapy for children with chronic immune deficiency disorder

Researchers at Karolinska Institutet in Sweden, and colleagues at University Children's Hospital Z-rich in Switzerland have managed to improve cytostatic therapy for children with the chronic immune deficiency disorder granulomatous disease prior to stem cell transplantation.

24 Oct 2013

Testosterone treatment in hypogonadal men may reduce cardiovascular disease risk

Research from Boston University School of Medicine suggests that testosterone treatment in hypogonadal (testosterone deficient) men restores normal lipid profiles and may reduce the risk of cardiovascular disease. These finding currently appear online in the International Journal of Clinical Practice.

24 Oct 2013

HIV testing more effective than brief patient-centered counseling in preventing AIDS

For decades, people seeking an HIV test have been counseled on realistic and achievable steps they could take to avoid infection. But a national study led by Miller School investigators has determined that, given the rapid HIV tests available today, the resources devoted to pre-test counseling would be better spent on universal testing that could detect more HIV cases earlier, and link newly infected people to the treatment that could halt the spread of the virus.

24 Oct 2013

Therapy News and Research

Pediatric asthma hospitalizations alert to poor disease management

Multifactorial approach needed for early bipolar detection

Full and early treatment may cure babies with HIV

CVS Caremark receives PBM and DTM accreditation from URAC

HM Hospitales expects to treat first patients with Elekta's Versa HD system in 2015

Study reveals that parental panic disorder affects children

Alexion Pharma's replacement therapy gets FDA Breakthrough Therapy designation for MoCD Type A

LCSB researchers publish current knowledge about the genetic, molecular causes of PD

Study reveals that tumors factors inhibit repair of damaged muscle fibers during cancer wasting

New Centre for Stratified Medicine opened in Ireland

Thomas Jefferson University’s interactive program discusses pros and cons of prostate cancer treatment

Leukemia drug reverses symptoms of colitis in lab tests

Researchers use nanopores to smuggle DNA or proteins across membranes

Patient assistance programs help breast cancer patients to learn more about adjuvant therapy

Kaiser Permanente researchers named co-recipients of Drug Therapy Research Literature Award

Diffregen awarded SBIR Phase 1 grant to advance Angiocidin towards human clinical trials

Metformin could serve as radiosensitizer to treat patients with stage III non-small cell lung cancer

Researchers improve cytostatic therapy for children with chronic immune deficiency disorder

Testosterone treatment in hypogonadal men may reduce cardiovascular disease risk

HIV testing more effective than brief patient-centered counseling in preventing AIDS

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News